SCHEMBL4362398

SCHEMBL4362398

CC(CCCCC(=O)O)c1cccs1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.54
TSHR P16473 2/20 0.44
ALOX5 P09917 1/20 0.42
LTB4R Q15722 1/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369043 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4375099 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4365212 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4366864 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4369023 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4368679 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4375048 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4365196 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4370817 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1
SCHEMBL4370716 0.98 HPGD (0.56) HPGDTSHRALOX5LTB4RHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765984-B2 Methods and systems for making thiol compounds from terminal olefinic compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-07-01 US disclosed
US-20120232297-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-09-13 US disclosed
WO-2009132010-A1 METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2009-10-29 WO disclosed
US-20090264669-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232297-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds TST, HHAT, GSTO1 HPGD 124/4885TSHR 4571/4885ALOX5 9/4885
US-20090264669-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds TST, HHAT, GSTO1 HPGD 124/4885TSHR 4571/4885ALOX5 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.